// App-Quantinova.ai

POS-020 : ENFORTUMAB VEDOTIN-INDUCED DIABETIC KETOACIDOSIS AND AKI: A CASE REPORT

Researchers

Presenter

  • H. Iftikhar

Principal Investigators

  • C. Khoury

Medical Centers

  • Washington University in Saint Louis, Nephrology, Saint Louis, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

  • Dermatology

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Advanced Urothelial Carcinoma

  • Stevens Johnson syndrome

  • Diabetic ketoacidosis

  • Bladder Cancer

  • Tubular injury

  • Renal insufficiency

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Enfortumab vedotin

  • Insulin regular

  • Carboplatin

  • Gemcitabine

  • Nivolumab

  • Insulin

Outcome

  • N/A

Study Design

  • Case report

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved